Indeed, work by Bergamaschi et al., found that, in an Italian cohort of MS patients and controls, a specific (and common) HLA-class I allele (HLA-A*02) mediated a protective effect, thus reducing MS risk in this population (Bergamaschi et al., 2010). Here, HLA-A is linked to myeloid sarcoma.